BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.71
+$0.05 (+1.07%)
Sep 22, 2026, 10:57 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -182.11M | -154.1M | -112.48M | -71.73M | -44.29M | -13.64M | -28.6M | -30.59M | -13.27M | -15.48M | -41.69K | -3.52K | -3.52K |
Depreciation & Amortization | 872K | 977K | 791K | 597K | 337K | 156K | 208K | 208K | 52K | 52K | n/a | n/a | n/a |
Stock-Based Compensation | 10.17M | 3.82M | 3.88M | 1.01M | 1.01M | 212.72K | 1.72M | 1.64M | 1.64M | 1.57M | n/a | n/a | n/a |
Other Working Capital | 12.79M | 4.39M | 12.89M | 16.98M | 18.11M | 11.71M | 16.93M | 16.91M | 5.37M | 5.25M | n/a | n/a | n/a |
Other Non-Cash Items | -37.8M | -33.38M | -37.5M | -39.66M | -36.68M | -38.73M | -39.66M | -37.37M | -3.65M | -1.21M | 41.69K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 15.73M | 10.61M | 8.42M | 15.04M | 16.16M | 11.81M | 16.75M | 16.62M | 5.08M | 4.96M | n/a | n/a | n/a |
Operating Cash Flow | -193.14M | -172.07M | -136.89M | -94.74M | -63.46M | -40.2M | -48.33M | -48.24M | -8.89M | -8.87M | n/a | n/a | n/a |
Capital Expenditures | -677K | -861K | -837K | -764K | -270K | -39K | -53K | -53K | -14K | -14K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -403.11M | -429.56M | -117.91M | -96.87M | -4.42M | 29.57M | 29.57M | 29.57M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 237.43M | 227.98M | 201.71M | 172.83M | 49.83M | 5.98M | 5.98M | 5.98M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 2.41M | 2.41M | 4.81M | 4.81M | 2.41M | 2.41M | n/a | n/a | n/a |
Investing Cash Flow | -166.35M | -202.44M | 82.97M | 75.2M | 47.55M | 37.91M | 40.31M | 40.31M | 2.39M | 2.39M | n/a | n/a | n/a |
Debt Repayment | 373.46M | 373.46M | 373.46M | 373.67M | 419.71K | 419.71K | 209.85K | n/a | -209.85K | -209.85K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12.4M | -15.66M | -15.54M | 172.08M | 184.84M | 188.1M | 188.31M | 1.27M | 209.85K | 209.85K | n/a | n/a | n/a |
Financial Cash Flow | 383.73M | 402.65M | 402.36M | 402.94M | 38.73M | 19.78M | 26.42M | 26.42M | 6.65M | 6.65M | n/a | n/a | n/a |
Net Cash Flow | 53.4M | 57.3M | 377.59M | 412.56M | 4.45M | -880.46K | 28.18K | 116.04K | 144.9K | 174K | n/a | n/a | n/a |
Free Cash Flow | -193.82M | -172.93M | -137.73M | -95.51M | -63.73M | -40.24M | -48.38M | -48.29M | -8.91M | -8.88M | n/a | n/a | n/a |
Adj. Free Cash Flow | -203.99M | -176.75M | -141.6M | -96.52M | -64.74M | -40.45M | -50.1M | -49.94M | -10.55M | -10.45M | n/a | n/a | n/a |
Maintenance CapEx | -560K | -694K | -670K | -597K | -220K | -39K | -53K | -53K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -117K | -167K | -167K | -167K | -50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -193.7M | -172.76M | -137.56M | -95.34M | -63.68M | -40.24M | -48.38M | -48.29M | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT